ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective.

Mark Kacar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.